Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular Age-related Macular Degeneration (AMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02061865
What this trial is testing

Phase 1 Safety Study With Intravitreal (IVT) REGN2176-3 in Patients Aged 50 Years and Older With Wet AMD

Who this might be right for
Neovascular Wet Age-related Macular Degeneration (AMD)
Regeneron Pharmaceuticals 12
Very early researchLooking for participantsNCT06031727
What this trial is testing

CRISPR/cas13-medIated RNA TarGeting THerapy for the Treatment of Neovascular Age-related Macular Degeneration Investigator-initiated Trial (SIGHT-I)

Who this might be right for
Neovascular Age-related Macular Degeneration(nAMD)
HuidaGene Therapeutics Co., Ltd. 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07766473
What this trial is testing

First in Human Study of BETA-TT8 in wetAge-related Macular Degeneration (wetAMD)

Who this might be right for
Neovascular (Wet) Age-Related Macular Degeneration
Filamon LTD 24
Post-approval studies (Phase 4)Study completedNCT01950741
What this trial is testing

Effect of Intravitreal VEGF-Trap Eye on Polypoidal Choroidal Vasculopathy

Who this might be right for
Exudative Age-related Macular DegenerationPolypoidal Choroidal Vasculopathy
Pusan National University Hospital 48
Post-approval studies (Phase 4)Study completedNCT03552770
What this trial is testing

Single or Combined Protocols for NV-AMD

Who this might be right for
Age-Related Macular Degeneration
University Hospital of Ferrara 109
Large-scale testing (Phase 3)Active Not RecruitingNCT06491914
What this trial is testing

A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME)

Who this might be right for
Neovascular Age-Related Macular DegenerationDiabetic Macular Edema
Regeneron Pharmaceuticals 1,126
Testing effectiveness (Phase 2)Ended earlyNCT04746963
What this trial is testing

Safety and Bioactivity of AXT107 in Subjects With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
AsclepiX Therapeutics, Inc. 3
Not applicableUnknownNCT00455871
What this trial is testing

Study of Treatment Effects of Combination Therapy of Lucentis Plus Reduced Fluence PDT With Visudyne in Patients With Exudative AMD

Who this might be right for
Age-Related Macular Degeneration
Barnes Retina Institute 30
Testing effectiveness (Phase 2)Study completedNCT02355028
What this trial is testing

LHA510 Proof-of-Concept Study as a Maintenance Therapy for Patients With Wet Age-Related Macular Degeneration

Who this might be right for
Exudative Age-Related Macular Degeneration
Alcon, a Novartis Company 136
Not applicableStudy completedNCT03939195
What this trial is testing

OCTA (Optical Coherence Angiography Tomography) Versus Structural OCT(Optical Coherence Tomography) in Neovascular AMD (Age Macular Degeneration)

Who this might be right for
Macular Degeneration Exudative Eye LeftMacular Degeneration Exudative Eye Right
Centre Hospitalier Intercommunal Creteil 130
Large-scale testing (Phase 3)Study completedNCT02698566
What this trial is testing

A Study in Patients With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Vein Occlusion to Evaluate Usability of the Ranibizumab (Lucentis®) Prefilled Syringe (PFS)

Who this might be right for
Macular Edema
Genentech, Inc. 35
Large-scale testing (Phase 3)UnknownNCT00148551
What this trial is testing

Triamcinolone Acetonide as an Adjunctive to VPDT in ARMD.

Who this might be right for
Age-Related Macular Degeneration
Canadian Retinal Trials Group 120
Large-scale testing (Phase 3)Ended earlyNCT04049266
What this trial is testing

Evaluate the Efficacy and Safety of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate, Versus Aflibercept in Patients With Neovascular (Wet) Age-Related Macular Degeneration.

Who this might be right for
Wet Macular Degeneration
Kodiak Sciences Inc 559
Post-approval studies (Phase 4)Study completedNCT02246829
What this trial is testing

Assessment of Early Changes in SD-OCT After Initiation of a Treatment by Intravitreal Aflibercept (EYLEA®)START

Who this might be right for
Neovascular Age-related Macular Degeneration of All Subtypes
University Hospital, Bordeaux 50
Not applicableStudy completedNCT04169802
What this trial is testing

Study Evaluating Retinal Health Monitoring System Visual Acuity Module.

Who this might be right for
Age Related Macular Degeneration
Kubota Vision Inc. 25
Not applicableEnded earlyNCT05266495
What this trial is testing

Effectiveness of Brolucizumab in Pre-treated Patients With nAMD in the Real-world Setting

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 3
Post-approval studies (Phase 4)Study completedNCT02843490
What this trial is testing

Functional and Structural Outcomes in Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Johannes Gutenberg University Mainz 71
Early research (Phase 1)Study completedNCT02530918
What this trial is testing

Study of DS-7080a for the Treatment of Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular DegenerationDiabetic Macular Edema
Daiichi Sankyo 56
Large-scale testing (Phase 3)WithdrawnNCT00557791
What this trial is testing

Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD (CARBON)

Who this might be right for
Age Related Macular Degeneration
OPKO Health, Inc.
Not applicableNot Yet RecruitingNCT07328776
What this trial is testing

AI vs. Physician for Anti-VEGF Decision-Making: An RCT

Who this might be right for
DMERetinal Vein Occlusion (RVO)Neovascular (Wet) Age-Related Macular Degeneration
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 200
Next Page